PW Medtech Group (1358.HK) Stock Price
PW Medtech Group Price
Revenue has compounded at 19.0% per year over the past 15 years to 960.26 M CNY. Earnings per share have grown at 4.4% per year over the last 13 years. PW Medtech Group's net margin stands at 11.5%, down from 272.3% several years earlier. PW Medtech Group currently offers a dividend yield of about 12.56%. The payout ratio is around 116% of earnings. The dividend has grown at 43.8% per year over the past 5 years.
PW Medtech Group stock price
PW Medtech Group business model & stock analysis
Frequently asked questions about PW Medtech Group
The business model of PW Medtech Group Ltd is focused on the development, manufacturing, and distribution of medical devices. As a leading healthcare company, PW Medtech Group Ltd works towards enhancing patient care by providing innovative and high-quality products. With a diverse portfolio, they cater to various medical fields including orthopedics, cardiovascular, and neurosurgery. Through strategic partnerships and acquisitions, PW Medtech Group Ltd aims to expand its market presence globally and strengthen its position as a trusted provider of medical solutions.
PW Medtech Group Ltd is primarily active in the medical technology industry.
The main competitors of PW Medtech Group Ltd in the market are [competitor1], [competitor2], and [competitor3]. These companies compete with PW Medtech Group Ltd in the [specific industry/sector]. While PW Medtech Group Ltd offers [specific products/services], its competitors also provide similar offerings to the market. This fierce competition drives innovation and pushes PW Medtech Group Ltd to constantly enhance its products and services to stay ahead in the market.
PW Medtech Group Ltd is a leading medical device company with a rich history and background. Established in [year], PW Medtech Group Ltd has become a trusted name in the industry, specializing in [specific medical devices or areas of expertise]. With a strong focus on innovation, quality, and customer satisfaction, the company has continually evolved and expanded its product portfolio. Renowned for its cutting-edge technology and commitment to improving patient outcomes, PW Medtech Group Ltd has earned a remarkable reputation worldwide. Leveraging its extensive experience and strategic partnerships, the company remains dedicated to driving advancements in the field of medical technology, making a positive impact on global healthcare.
PW Medtech Group Ltd has achieved several significant milestones throughout its history. As a leading medical device company, PW Medtech has constantly strived to innovate in the healthcare industry. Some notable accomplishments include successful product launches, expansion into new markets, and strategic collaborations with renowned institutions. The company has also received numerous awards and recognition for its contributions to the medical field. These achievements are a testament to PW Medtech's commitment to delivering high-quality medical solutions and improving patient care.
PW Medtech Group Ltd is primarily present in China and the Asia-Pacific region. With its headquarters located in China, PW Medtech Group Ltd focuses on the development and manufacturing of medical devices and equipment. It has a strong presence in major cities and provinces across China, where it serves a significant market share. Additionally, PW Medtech Group Ltd has expanded its operations in the Asia-Pacific region, including countries such as Japan, South Korea, Singapore, and Australia. By strategically targeting these regions, PW Medtech Group Ltd aims to capitalize on the growing demand for advanced medical technology and enhance its global footprint.
PW Medtech Group Ltd represents values of innovation, excellence, and integrity. As a medical technology company, they prioritize delivering advanced and reliable solutions to improve patients' lives. Their corporate philosophy revolves around continuous research and development, ensuring high product quality and safety standards. PW Medtech Group Ltd is committed to collaborative partnerships with healthcare professionals, fostering trust and providing tailored solutions to meet evolving medical needs. With a customer-centric approach, they aim to enhance the overall healthcare experience and contribute to the sustainable development of the industry.
9 analysts currently rate the PW Medtech Group stock: 0 recommend buying, 3 holding and 6 selling.
Converted at the current exchange rate, the PW Medtech Group share trades at 0.10 EUR (0.77 CNY).
The PW Medtech Group share (1358.HK) is listed on 2 stock exchanges, including: Hongkong (HKEX) (1358.HK), Frankfurt (PWE.F).
The PW Medtech Group Ltd is a leading company in the field of medical technology, specializing in the manufacturing and sale of products and services related to medical devices. The company is headquartered in Hong Kong and has branches in China, Hong Kong, and Singapore. The business model of the PW Medtech Group Ltd includes several divisions, including the manufacturing of medical devices, the development and marketing of medications, and the provision of medical services. The different divisions complement each other and allow the company to offer a comprehensive range of products and services tailored to the needs of customers. The manufacturing of medical devices is one of the main divisions of the PW Medtech Group Ltd. The company produces a variety of devices, including surgical instruments, implants, artificial joints, and other medical devices. PW Medtech Group's products are known for their high quality, reliability, and innovative features that meet the needs of doctors and patients. Another important division of the company is the development and marketing of medications. In recent years, PW Medtech Group has developed and brought to market a wide range of medications, including drugs for the treatment of cancer, diabetes, and other chronic diseases. By developing and marketing medications, the company makes a significant contribution to improving healthcare. In addition to manufacturing medical devices and developing medications, PW Medtech Group Ltd also offers a range of medical services. These include providing consulting services to doctors and hospitals, training for medical personnel, and diagnostic and treatment services for patients. These services are of great value to customers and contribute to making PW Medtech Group Ltd a comprehensive provider of medical technology. The products offered by PW Medtech Group Ltd include a wide range of medical devices and consumables. These include surgical instruments, implants, artificial joints, wound dressings, bandages, gloves, and masks. All products have been carefully designed and tested to ensure the highest standards of quality and safety. In summary, the business model of the PW Medtech Group Ltd is based on a wide range of products and services in the field of medical technology. The different divisions complement each other and allow the company to provide a comprehensive range of products and services that meet the needs of customers. By providing high-quality medical technology and medications, as well as top-notch medical services, PW Medtech Group Ltd makes a significant contribution to improving healthcare and enhancing the quality of life for patients.
The revenue cannot currently be calculated for PW Medtech Group.
The profit cannot currently be calculated for PW Medtech Group.
The P/E ratio cannot be calculated for PW Medtech Group at the moment.
The P/S cannot be calculated for PW Medtech Group currently.
The Eulerpool Quality Score for PW Medtech Group is 3/10.
The ISIN of PW Medtech Group is KYG7306W1087. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of PW Medtech Group is A1W74W. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of PW Medtech Group is 1358.HK. The ticker symbol is used to trade PW Medtech Group shares on the stock exchange.
PW Medtech Group stock
PW Medtech Group Peer Group
PW Medtech Group Ticker
PW Medtech Group FIGI
All fundamentals and in-depth analysis of PW Medtech Group
Our stock analysis for PW Medtech Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PW Medtech Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.